WeVote

Bill

Bill

SB 1392

Relating to newborn screening tests for sex chromosome structure.

89th Legislature (2025) Introduced by Bob Hall

SB 1392 would add sex chromosome structure testing to Texas newborn screening, enabling early detection of conditions like XXY and X0 variations for potential medical intervention and family counseling.

Referred to Health & Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 1392

Legislative bill overview

SB 1392 would establish or modify newborn screening protocols in Texas to include testing for sex chromosome structure variations (such as XXY, XYY, X0, and similar conditions). The bill specifically addresses how Texas identifies and manages infants born with atypical sex chromosome configurations through its newborn screening program.

Why is this important

Newborn screening for sex chromosome variations could enable early identification of conditions that may affect development, fertility, or health outcomes, potentially allowing for earlier medical intervention and family counseling. However, this testing raises significant questions about medical necessity, parental notification, and how results are communicated and managed during a child's development.

Potential points of contention

  • Medical necessity and utility: Debate over whether screening for sex chromosome variations without immediate health consequences is medically justified, versus whether early knowledge enables better health management
  • Informed consent and transparency: Questions about how parents are informed about these conditions, what the results mean developmentally, and concerns about medicalization of natural human variation
  • Privacy and psychological impact: Concerns about how knowledge of atypical sex chromosomes might affect family dynamics and the child's identity development, particularly for variations that may have minimal health impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.